Eli Lilly and Company Issues Voluntary Nationwide Recall of One Lot of GLUCAGON® Emergency Kit Due to Loss of Potency
Retrieved on:
Saturday, September 25, 2021
Online, Degenerative disease, BRC, Food, Dizziness, Tremor, Completeness, LLY, Neoplasm, Exocrine gland, Hunger, Tongue, Blood pressure, Pulse, Compliance, Quarantine, Somnolence, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Fax, Lactose, Extrapyramidal system, Sleep, FDA, Patient, Grammatical mood, Allergy, Adult, Insulinoma, Glucagonoma, Radical behaviorism, Pheochromocytoma, Restless, Paresthesia, Irritability, Expiration, Personality, Diabetes, Interactivity, Freepost, Death, Perspiration, Knowledge, Lightheadedness, Confusion, Headache, Injection, Nerve, Pancreas, Hypoglycemia, Safety, Consciousness, NYSE, Anxiety, Seizure, Sedgwick, Pharmaceutical industry, Dietary supplement, Medical imaging, Liquor
The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency.
Key Points:
- The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency.
- Glucagon Emergency Kit is used as an anti-hypoglycemic agent and a gastrointestinal motility inhibitor indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus.
- The affected Glucagon Emergency Kit lot is D239382D and the expiration date is April 2022 (label expiry date: 04 2022).
- Wholesalers and Distributors with an existing inventory of Glucagon Emergency Kit lot D239382D should cease distribution and quarantine the product immediately.